Friday broker round-up - UPDATE

AstraZeneca: Credit Suisse maintains underperform rating and 2,600p target.ASOS: HSBC upgrades from neutral to overweight, target cut from 1,900p to 1,780p.Barclays: Nomura reiterates neutral recommendation and 268p target.British American Tobacco: Jefferies maintains buy recommendation and 3,600p target.British Land: JP Morgan Cazenove upgrades from neutral to overweight.BT Group: Goldman Sachs upgrades from buy to conviction buy.Chemring: Arden Partners upgrades from add to buy.CRH: JP Morgan Cazenove upgrades from underweight to overweight.Elementis: UBS raises target from 200p to 220p, buy rating kept.Man Group: Societe Generale upgrades from hold to buy.Salamander Energy: Investec downgrades from buy to hold, target cut from 296p to 250p.Shire Pharmaceuticals: Credit Suisse keeps outperform rating and 2,350p target.Royal Dutch Shell: Credit Suisse reiterates neutral recommendation and 2,530p target.Unilever: HB Markets upgrades from sell to hold.Whitbread: Credit Suisse raises target from 1,818p to 2,000p, neutral rating unchanged.BC Astrazeneca Barclays British Land Man Unilever British American Tobacco Whitbread BT ASOS Elementis Chemring